Cassava Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.About SAVA
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.
CEORichard Jon Barry
CEORichard Jon Barry
Employees30
Employees30
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1998
Founded1998
Employees30
Employees30
SAVA Key Statistics
Market cap143.47M
Market cap143.47M
Price-Earnings ratio-1.16
Price-Earnings ratio-1.16
Dividend yield—
Dividend yield—
Average volume1.03M
Average volume1.03M
High today$2.99
High today$2.99
Low today$2.79
Low today$2.79
Open price$2.88
Open price$2.88
Volume817.22K
Volume817.22K
52 Week high$33.98
52 Week high$33.98
52 Week low$1.15
52 Week low$1.15
Stock Snapshot
Cassava Sciences(SAVA) stock is priced at $2.99, giving the company a market capitalization of 143.47M. It carries a P/E multiple of -1.16.
As of 2025-11-08, Cassava Sciences(SAVA) stock has fluctuated between $2.79 and $2.99. The current price stands at $2.99, placing the stock +7.1% above today's low and -0.0% off the high.
The Cassava Sciences(SAVA)'s current trading volume is 817.22K, compared to an average daily volume of 1.03M.
In the last year, Cassava Sciences(SAVA) shares hit a 52-week high of $33.98 and a 52-week low of $1.15.
In the last year, Cassava Sciences(SAVA) shares hit a 52-week high of $33.98 and a 52-week low of $1.15.
People also own
Based on the portfolios of people who own SAVA. This list is generated using Robinhood data, and it’s not a recommendation.